2 DOSAGE AND ADMINISTRATION
2.1 General Administration
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer unless solution is clear and seal is intact. Each syringe is intended for single dose only. Discard unused portion.
For intravenous administration.
Titrate based on heart rate, PR interval, blood pressure and symptoms.
2.2 Adult Dosage
Use | Dose (adults) | Repeat |
Antisialagogue or other antivagal | 0.5 to 1 mg | 1-2 hours |
Organophosphorus or muscarinic mushroom poisoning | 2 to 3 mg | 20-30 minutes |
Bradyasystolic cardiac arrest | 1 mg | 3-5 minutes; 3 mg maximum total dose |
2.3 Pediatric Dosage
Dosing in pediatric populations has not been well studied. Usual initial dose is 0.01 to 0.03 mg/kg.
2.4 Dosing in Patients with Coronary Artery Disease
Limit the total dose of atropine sulfate to 0.03 mg/kg to 0.04 mg/kg [see Warnings and Precautions (5.1)].